RNTX
Rein Therapeutics·NASDAQ
--
--(--)
--
--(--)
RNTX fundamentals
Rein Therapeutics (RNTX) released its earnings on Nov 14, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.21 (YoY +22.22%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.21
+22.22%
Report date
Nov 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Rein Therapeutics (RNTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Rein Therapeutics (RNTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Rein Therapeutics (RNTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Rein Therapeutics (RNTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Rein Therapeutics (RNTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Rein Therapeutics (RNTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Rein Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Rein Therapeutics year over year?What were the key takeaways from Rein Therapeutics's earnings call?What were the key takeaways from Rein Therapeutics’s earnings call?Did Rein Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Rein Therapeutics's revenue and profit?What is Rein Therapeutics's gross profit margin?What is the market's earnings forecast for Rein Therapeutics next quarter?
